Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World’s First Clinical Trial Utilizing Blockchain Technology

– Introducing digital transformation (DX) for monitoring work and reducing new drug development costs – TOKYO–(BUSINESS WIRE)–Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Minato-ku, Tokyo, President and CEO: Kazunari Tsunaba), a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, … [Read more…]

Humanigen Receives Preliminary Topline Data From NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B

SHORT HILLS, N.J.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”) has been informed of preliminary topline results from the National Institute of Allergy and Infectious Diseases’ (NIAID) ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospitalized COVID-19 patients. The trial did not achieve statistical significance on the primary endpoint, which was defined as the … [Read more…]

ByteDance Invests in the Cryo-EM & AI Powered Biotech Startup Shuimu BioSciences

BOSTON–(BUSINESS WIRE)–#biotech–ByteDance has pitched into life sciences. Last October, this internet tech giant invested in the biotech startup Shuimu BioSciences (Shuimu), a company leveraging the power of cryogenic electron microscopy (cryo-EM) and AI to revolutionize drug discovery. Since the outbreak of the coronavirus, life sciences has become one of the most promising sectors to venture … [Read more…]

Children’s Hospital Los Angeles Names Ashish Buttan Vice President, Physician Partnerships

LOS ANGELES–(BUSINESS WIRE)–Ashish Buttan, BDS, MBA, has been promoted to Vice President, Physician Partnerships at Children’s Hospital Los Angeles (CHLA). This new role expands his existing responsibilities as Executive Director of the Neurological Institute and the Behavioral Health Institute to include physician alignment, stewardship and performance management with CHLA’s five academic departments and the Children’s … [Read more…]

Biocom California Applauds Supervisor Holly Mitchell and LA County Board of Supervisors for Expanding Life Sciences Industry Support and Creation of Equitable, High-road Career Opportunities for Local Communities

LOS ANGELES–(BUSINESS WIRE)–Today the Los Angeles County Board of Supervisors approved a motion by Supervisor and Chair of the Board Holly Mitchell, which will help focus County resources on growing LA’s life sciences industry. As the fastest growing segment of Los Angeles’ economy, LA County’s life sciences sector employs nearly 100,000 people and is home … [Read more…]

Trousdale Medical Center Named LifePoint Health National Quality Leader

Hartsville hospital recognized for achievements in patient and family engagement, quality care and patient safety HARTSVILLE, Tenn.–(BUSINESS WIRE)–Trousdale Medical Center (TMC), a member of HighPoint Health System, today announced that it has been named a LifePoint Health National Quality Leader. This designation recognizes hospitals within the LifePoint Health system that have enrolled in the LifePoint … [Read more…]

SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ® APCs and Effective CD8 T Cell Activation

ESMO Immuno-Oncology and Technology Article Details Importance of Intracellular Delivery to Drive Effective MHC-I Mediated Activation of CD8 T Cells Paper Highlights Preclinical SQZ® APC Combination Data with PD-1 IL2v and Manufacturing Benefits of the Cell Squeeze® Technology WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for … [Read more…]

Pacific Life Updates Underwriting Guidelines to Expand Life Insurance Options to Individuals Living With HIV

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Pacific Life has expanded its offering of life insurance coverage to eligible individuals living with human immunodeficiency virus (HIV). “In keeping with our progressive approach to underwriting, we are leveraging the latest medical advancements in therapeutics for HIV in order to offer coverage to individuals living with this chronic condition,” said Dawn … [Read more…]

Atara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS

 Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment   IDSMC Did Not Identify Any Safety Concerns Phase 2 Study Target Enrollment Achieved; Final Data and Communication Expected in October 2023 Conference Call and Webcast Today at 2:00 p.m. PDT/5:00 p.m. EDT SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), … [Read more…]